UNDERWRITING AGREEMENTUnderwriting Agreement • May 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations • New York
AMENDED AND RESTATED SUBORDINATION AGREEMENTSubordination Agreement • May 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED SUBORDINATION AGREEMENT is entered into effective as of May 2, 2016, among the parties identified on Schedule A hereto (the “Subordinated Lenders”), PhaseRx, Inc., a Delaware corporation (the “Borrower”), Titan Multi-Strategy Fund I, LTD., in its capacity as a Senior Lender (as defined below) and in its capacity as representative for itself and for the other Senior Lenders (the “Representative”), the parties identified on Schedule B hereto (together with the Representative, are collectively referred to herein as the “Initial Senior Lenders”), and the parties identified on Schedule C hereto (the “Additional Senior Lenders”, together with the Initial Senior Lenders, are collectively referred to herein as the “Senior Lenders”).
